In the News

BioWorld Covers Dykema Webinar Featuring Mansour and Shapiro-Barr Addressing De Novo Classification for Medical Devices

May 28, 2021

Mark Mansour, Washington, D.C.-based Member in Dykema’s Health Care Practice Group, and Tania Shapiro-Barr, Minneapolis-based Member in the Firm’s Intellectual Property Practice Group, were quoted in the BioWorld article, “De novo petitions not the same as patent protection, but some exclusivity available.”

The article summarized a recent Dykema webinar, “The Intersection of Regulatory and Intellectual Property Issues in the Medical Device World,” hosted by Mansour and Shapiro-Barr in which they discussed the importance of labeling de novo devices in an “innovative manner” to help fend off the uncertainty of patent protection and provide a competitive advantage.

BioWorld subscribers may find the entire article here.